Skip to main content

Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit

Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit

Jury Announces Mistrial in a J&J Talc-Asbestos Lawsuit

Introduction

A South Carolina jury failed to arrive at a unanimous decision whether Johnson & Johnson was responsible for the death of the 30-year old attorney, whose family claimed she suffered from mesothelioma due to the exposure to J&J's talcum powder containing asbestos traces.

A lawyer for the family insists that the daily use of baby powder led to the death and stated they will retry the case soon. The other defendants, in this case, were the U.S. unit of talc supplier Imerys SA, and a local unit of drugstore chain Rite Aid.

J&J is facing around 9,000 cases over claims that its talcum use led to the diagnosis of ovarian cancer in women due to traces of asbestos present as an ingredient in the baby powder when used for feminine hygiene purposes.

Similar allegations are filed against J&J in state courts in California, New Jersey, and Delaware and consolidated for pre-trial proceedings in the U.S. District Court for the District of New Jersey MDL No. 2738 (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!